PAHC Common Stock · Transaction Sep 1, 2022 · Filed Oct 13, 2022 · Amount pending receipt enrichment
NASDAQ NMS - GLOBAL MARKET · PAHC
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Phibro Animal Health Corp
Pharmaceuticals
$34.63
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · PAHC
MethodologyPAHC
Phibro Animal Health Corp
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
53/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is PAHC moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Phibro Animal Health Corp
PHARMACEUTICAL PREPARATIONSListed since
2014
Employees
2K
Country
US
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$34.63
Last session
Day high
$34.63
Last session
Day low
$34.63
Last session
Previous close
$34.63
52W high
$59.58
-41.88% from high
52W low
$28.52
20% of range
Market cap
$1.4B
P/E
14.31×
EPS
$2.42
Beta
0.84
Shares out
40.6M
Avg volume
222.8K
VWAP
$34.63
Last session
Price history computed in-house
1W
+1.61%
1M
+3.96%
3M
+2.43%
1Y
+10.82%
YTD
-7.31%
SMA 50 $33.38 · above
SMA 200 $42.33 · below
52W position 20%
PAHC overview
Related filings and maps
Public disclosures
Congress activity in PAHC
Official filing ↗
PAHC Common Stock · Transaction Aug 30, 2022 · Filed Sep 19, 2022 · Amount pending receipt enrichment
PAHC Common Stock · Transaction Mar 4, 2022 · Filed Apr 18, 2022 · Amount pending receipt enrichment
PAHC Common Stock · Transaction Mar 2, 2022 · Filed Apr 18, 2022 · Amount pending receipt enrichment
PAHC Common Stock · Transaction Dec 14, 2021 · Filed Jan 27, 2022 · Amount pending receipt enrichment
Federal contracts
PAHC contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PAHC in this window.
Lobbying spend
PAHC lobbying filings, year to date.
Registered lobbying filings matched to Phibro Animal Health Corp.
$510.0K
Refresh interval: 12hSource: LDA disclosure filings
Animals
Science/TechnologyAgriculture
Filing
$150.0K
PHIBRO ANIMAL HEALTH CORPORATION
CHECKMATE GOVERNMENT RELATIONS
Jul 16, 2026
Filing
$150.0K
PHIBRO ANIMAL HEALTH CORPORATION
CHECKMATE GOVERNMENT RELATIONS
Apr 16, 2026
Filing
$150.0K
PHIBRO ANIMAL HEALTH CORPORATION
CHECKMATE GOVERNMENT RELATIONS
Jan 20, 2026
Analyst ratings
Sovereign unlock shows live analyst consensus for PAHC.
Options
Sovereign unlock shows live options positioning for PAHC.